Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Telik Awarded $1.2 Million in Grants for Qualifying Therapeutic Development Projects

November 2, 2010 7:34 pm | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Nov. 2, 2010 /- Telik, Inc. (Nasdaq: TELK ) a clinical stage drug development company focused on developing drugs to treat cancer, announced that it has been awarded grants totaling $1,222,396 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP)....

TOPICS:

Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in...

November 2, 2010 7:33 pm | by Bio-Medicine.Org | News | Comments

BASKING RIDGE, N.J., Nov. 2, 2010 /- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Steven L. Zelenkofske, D.O., F.A.C.C., Senior Vice President and Chief Medical Officer, presented an...

TOPICS:

Anthem Blue Cross Blue Shield Introduces Cost Disclosure Tool Throughout Colorado

November 2, 2010 3:33 pm | by Bio-Medicine.Org | News | Comments

DENVER, Nov. 2, 2010 /- Anthem Blue Cross and Blue Shield in Colorado announced today the expansion of its industry-leading transparency initiative beyond major metro areas into the entire state.  Colorado members from Silverton to Sterling and everywhere in between can now access...

TOPICS:
Advertisement

Improving health care in the Internet age

November 2, 2010 1:35 pm | by EurekAlert | News | Comments

(Inderscience Publishers) Faster and more widely available internet access has improved our lives in many ways but health care is lagging behind, according to researchers writing in the International Journal of Medical Engineering and Informatics.

TOPICS:

Power GaN: Market & Technology Analysis - Report from Yole Développement

November 2, 2010 12:38 pm | by I-Micronews | News | Comments

GaN Technologies for Power Electronics Applications: Industry and Market Status & Forecasts

Sapphire Market 2010, Q4 Update - A report from Yole Développement

November 2, 2010 12:38 pm | by I-Micronews | News | Comments

Acute material shortage sent 2? wafer prices in the low $30?s. Shortage to be resolved by mid 2011

New Deloitte Recap Report Identifies Strategies to Help Reduce Development Times and Increase Success Rates for Cancer Drugs

November 2, 2010 12:36 pm | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO, Nov. 2, 2010 /- Deloitte released a new report, "Innovative Strategies for Oncology Drug Development," highlighting specific drug development approaches that have enabled biotech companies to produce a substantial number of first-in-class compounds and more than $1 billion...

TOPICS:

Cannabis Science Announces a Proposed 10:1 Ratio Structured Dividend Payout for a New Class of Common Shares to Shareholders of Record as of November 30, 2010

November 2, 2010 12:36 pm | by Bio-Medicine.Org | News | Comments

COLORADO SPRINGS, Colo., Nov. 2, 2010 /- Cannabis Science, Inc. (OTC Bulletin Board: CBIS ), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce to its shareholders and the investment community that its Board of Directors have confirmed...

TOPICS:
Advertisement

Parkinson disease study now enrolling

November 2, 2010 12:36 pm | by Baylor College of Medicine | News | Comments

Enrollment has begun in a new double-blind Phase 2b study evaluating CERE-120 in Parkinson's disease patients. Baylor College of Medicine is one of eight clinical sites enrolling along with 11 major medical centers across the country. CERE-120 is a gene therapy product that delivers the...

TOPICS:

Deadline for Stand Up To Cancer's Innovative Research Grant Letters of Intent Fast Approaching

November 2, 2010 12:34 pm | by AACR | News | Comments

PHILADELPHIA - The American Association for Cancer Research reminds the cancer research community that the Letters of Intent deadline for Stand Up To Cancer's Innovative Research Grants (IRG) is less than two weeks away.

TOPICS:

Mednax 3Q profit rises 27 percent

November 2, 2010 11:45 am | by The Associated Press | News | Comments

National physician group Mednax Inc. said Tuesday that its third-quarter profit rose 27 percent as contributions from newly acquired practices helped boost revenue.Mednax earned $61.3 million, or $1.29 per share, up from $48.1 million, or $1.03 per share, in the same quarter last year. Revenue...

Emergency Medical Services 3Q profit rises

November 2, 2010 11:45 am | by The Associated Press | News | Comments

GREENWOOD VILLAGE, Colo. (AP) — Ambulance services provider Emergency Medical Services Corp. said Tuesday its third-quarter net income rose 27 percent on a boost in new contracts and acquisitions.EMS reported net income of $36.8 million, or 82 cents per share, up from $28.9 million, or 66 cents per...

Genstruct names systems biology vet Levine to board

November 2, 2010 10:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Genstruct Inc., a systems biology firm located in Cambridge, has appointed oncology and systems biology leader Arnold Levine to the company's board of directors.

Ironwood inches toward NDA on positive Phase 3 results

November 2, 2010 10:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

A treatment for irritable bowel syndrome developed by Cambridge-based Ironwood Pharmaceuticals Inc. and partner Forest Laboratories Inc., of New York, has achieved positive results in a second Phase 3 clinical trial, meeting both primary and secondary endpoints.

Curemark Awarded Qualifying Therapeutic Discovery Project (QTDP) Grant

November 2, 2010 10:36 am | by Bio-Medicine.Org | News | Comments

RYE, N.Y., Nov. 2, 2010 /- Curemark LLC , a drug research and development company focused on the treatment of neurological diseases, announced today that it has been awarded a grant by the United States government under the Qualifying Therapeutic Discovery Project (QTDP) Program to...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading